LUCD
Lucid Diagnostics Inc.NASDAQHealthcare$1.14-0.87%ClosedMarket Cap: $116.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
10.63
P/S
0.02
EV/EBITDA
614.66
DCF Value
$-17,450.79
FCF Yield
-40.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-0.1%
Operating Margin
-1.1%
Net Margin
-1.2%
ROE
-591.1%
ROA
21.1%
ROIC
-0.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $4.70B | -0.0% | $-14.0M | $-16.3M | $-0.12 | — |
| FY 2025 | $4.71B | -41.7% | $-49.6M | $-58.0M | $-0.69 | — |
| Q3 2025 | $1.2M | -58.3% | $-11.8M | $-10.4M | $-0.10 | — |
| Q2 2025 | $1.2M | -53.5% | $-11.4M | $-4.4M | $-0.08 | — |
| Q1 2025 | $828.0K | -87.3% | $-12.5M | $-26.9M | $-0.52 | — |
| Q4 2024 | $1.2M | -79.2% | $-12.4M | $-11.5M | $-0.20 | — |
| FY 2024 | $4.3M | -90.2% | $-46.1M | $-45.5M | $-1.05 | — |
| Q3 2024 | $1.2M | -43.7% | $-11.7M | $-12.4M | $-0.25 | — |
| Q2 2024 | $976.0K | -65.4% | $-11.2M | $-11.0M | $-0.23 | — |
| Q1 2024 | $1.0M | -65.4% | $-10.8M | $-10.6M | $-0.40 | — |
| Q4 2023 | $1.0M | -40.1% | $-11.5M | $-10.8M | $-0.26 | — |
| FY 2023 | $2.4M | -249.2% | $-48.5M | $-52.7M | $-1.26 | — |